Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Current Opinion in Nephrology and Hypertension|April 14, 2017
Vasopressin and diabetic nephropathyRonan Roussel, Gilberto Velho, Lise Bankir
American Journal of Physiology. Renal Physiology|May 1, 2015
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaLise Bankir, Ronan Roussel, Nadine Bouby
Journal of Diabetes and Its Complications|April 17, 2017
Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetesRay El Boustany, Christopher Taveau, Catherine Chollet, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 22, 2016
Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V<sub>1A</sub> receptorsChristopher Taveau, Catherine Chollet, Daniel G Bichet, et al.
Cardiovascular Diabetology|May 14, 2021
SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesisLouis Potier, Kamel Mohammedi, Gilberto Velho, et al.
The Journal of Clinical Endocrinology and Metabolism|April 7, 2016
Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the CommunityRonan Roussel, Ray El Boustany, Nadine Bouby, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2014
Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney diseaseRonan Roussel, Léopold Fezeu, Michel Marre, et al.
Diabetes Care|October 13, 2016
Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 DiabetesGilberto Velho, Ray El Boustany, Guillaume Lefèvre, et al.
American Journal of Nephrology|September 9, 2015
Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. StudyRonan Roussel, Nadia Matallah, Nadine Bouby, et al.
Diabetes Research and Clinical Practice|October 20, 2018
Glucagon revisited: Coordinated actions on the liver and kidneyLise Bankir, Nadine Bouby, Robert C Speth, et al.
Pageof 28